Cite
HARVARD Citation
Rosenkranz, S. et al. (2022). The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study. European journal of heart failure. pp. 205-214. [Online].